Ypke van Oosterhout

A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease

Ypke van Oosterhout, Liesbeth van Emst, A Schattenberg et al. · Blood · 2000 · 35 citations

Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease

Christoph Groth, Lenneke F. J. van Groningen, Tiago R. Matos et al. · Biology of Blood and Marrow Transplantation · 2018 · 34 citations · Full text

Highly potent CD22-recombinant ricin A results in complete cure of disseminated malignant B-cell xenografts in SCID mice but fails to cure solid xenografts in nude mice

P. J. VAN HORSSEN, Frank Preijers, Ypke van Oosterhout et al. · International Journal of Cancer · 1996 · 20 citations · Full text

Cytotoxic Potency of CD22‐Ricin A Depends on Intracellular Routing Rather than on the Number of Internalized Molecules

P. J. VAN HORSSEN, Ypke van Oosterhout, T. de Witte et al. · Scandinavian Journal of Immunology · 1995 · 15 citations · Full text

A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease

Ypke van Oosterhout, Liesbeth van Emst, A Schattenberg et al. · Blood · 2000 · 15 citations